We are live on ! Find out more
GNMK

GenMark Diagnostics, Inc
GNMK

Delisted

GNMK was delisted on the 21st of April, 2021.

Back to rankings

110 hedge funds and large institutions have $320M invested in GenMark Diagnostics, Inc in 2019 Q3 according to their latest regulatory filings, with 17 funds opening new positions, 43 increasing their positions, 25 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

72% more repeat investments, than reductions

Existing positions increased: 43 | Existing positions reduced: 25

42% more first-time investments, than exits

New positions opened: 17 | Existing positions closed: 12

4% more funds holding

Funds holding: 106 → 110 (+4)

6% less capital invested

Capital invested by funds: $339M → $320M (-$19.3M)

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $46K

Holders
110
Holders Change
+4
Holders Change %
+3.77%
% of All Funds
2.41%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
17
Increased
43
Reduced
25
Closed
12
Calls
–
Puts
$46K
Net Calls
-$46K
Net Calls Change
+$3K

Top Buyers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
+$14.2M
2
BlackRock
BlackRock
New York
+$2.65M
3
State of New Jersey Common Pension Fund D
State of New Jersey Common Pension Fund D
New Jersey
+$2.23M
4
EIM
Essex Investment Management
Massachusetts
+$1.79M
5
QI
QS Investors
New York
+$1.7M

Top Sellers

Rank Fund Capital Flow
1
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$22.4M
2
Assenagon Asset Management
Assenagon Asset Management
Luxembourg
-$2.45M
3
HighTower Advisors
HighTower Advisors
Illinois
-$1.67M
4
JP Morgan Chase
JP Morgan Chase
New York
-$1.66M
5
Federated Hermes
Federated Hermes
Pennsylvania
-$1.3M
Name Holding Trade Value Shares
Change 		Change in
Stake
Two Sigma Investments
26
Two Sigma Investments
New York
$2.06M -$2.8K -448 -0.1%
Charles Schwab
27
Charles Schwab
California
$1.92M -$57.6K -9,231 -3%
EIM
28
Essex Investment Management
Massachusetts
$1.74M +$1.79M +286,618 New
Squarepoint
29
Squarepoint
New York
$1.72M +$629K +100,768 +55%
QI
30
QS Investors
New York
$1.65M +$1.7M +272,600 New
MAG
31
Millrace Asset Group
Pennsylvania
$1.6M +$97.6K +15,635 +6%
Deutsche Bank
32
Deutsche Bank
Germany
$1.57M -$386K -61,929 -19%
Two Sigma Advisers
33
Two Sigma Advisers
New York
$1.53M +$115K +18,500 +8%
NIM
34
Needham Investment Management
New York
$1.51M +$374K +60,000 +32%
Bank of New York Mellon
35
Bank of New York Mellon
New York
$1.43M +$49.2K +7,883 +3%
PAM
36
Panagora Asset Management
Massachusetts
$1.38M +$1.11M +177,782 +357%
Wells Fargo
37
Wells Fargo
California
$1.27M +$24.9K +3,983 +2%
OAM
38
Oxford Asset Management
United Kingdom
$1.1M -$410K -65,712 -26%
TD Asset Management
39
TD Asset Management
Ontario, Canada
$847K -$77.5K -12,418 -8%
AQR Capital Management
40
AQR Capital Management
Connecticut
$763K +$522K +83,656 +198%
Tudor Investment Corp
41
Tudor Investment Corp
Connecticut
$745K +$467K +74,882 +156%
Swiss National Bank
42
Swiss National Bank
Switzerland
$587K – – –
Man Group
43
Man Group
United Kingdom
$577K -$317K -50,846 -35%
RhumbLine Advisers
44
RhumbLine Advisers
Massachusetts
$563K -$18.4K -2,950 -3%
WMSA
45
Weiss Multi-Strategy Advisers
New York
$545K -$125K -20,000 -18%
California State Teachers Retirement System (CalSTRS)
46
California State Teachers Retirement System (CalSTRS)
California
$508K – – –
Jacobs Levy Equity Management
47
Jacobs Levy Equity Management
New Jersey
$489K +$503K +80,627 New
HSBC Holdings
48
HSBC Holdings
United Kingdom
$472K +$486K +77,838 New
William Blair & Company
49
William Blair & Company
Illinois
$466K -$103K -16,432 -18%
Los Angeles Capital Management
50
Los Angeles Capital Management
California
$453K +$466K +74,697 New
1
2
3 4 5

GNMK Hedge Fund Activity: Q3 2019 in Review

110 of the 4,561 institutional investors tracked by Wall St. Rank reported a position in GenMark Diagnostics, Inc (GNMK) for Q3 2019, worth a combined $320M — down 5.7% from $339M a quarter earlier.

Buyers outnumbered sellers: 17 funds opened new GNMK positions and 12 closed out — a net gain of 5 holders — while 43 added to existing stakes and 25 trimmed.

The largest buyer was Morgan Stanley, adding an estimated $14.2M. The largest seller was T. Rowe Price Associates, cutting an estimated $22.4M.

  • 110 institutional investors held GenMark Diagnostics, Inc (GNMK) as of Q3 2019, up from 106 in Q2 2019.
  • Funds reported $320M of GenMark Diagnostics, Inc stock for Q3 2019, down 5.7% quarter-over-quarter.
  • 17 funds opened new GenMark Diagnostics, Inc positions in Q3 2019 and 12 closed out, a net change of +5 holders.
  • The largest GenMark Diagnostics, Inc buyer in Q3 2019 was Morgan Stanley, an estimated $14.2M added.
  • The largest GenMark Diagnostics, Inc seller in Q3 2019 was T. Rowe Price Associates, an estimated $22.4M sold.

Based on aggregated 13F filings for Q3 2019.